On September 13, 2022, Representatives Ami Berra (D-CA-7) and Larry Bucshon (R-IN-8) introduced the Supporting Medicare Providers Act of 2022 (H.R. 8800), which aims to infuse the Medicare Physician Fee Schedule (MPFS) with a 4.42% funding increase for 2023. With a bipartisan coalition of 12 co-sponsors, the bill would have the practical effect of negating the impending 4.42% cut to the MPFS conversion factor. This Health Capital Topics article will review the bill, discuss its support, and examine its potential implications. (Read more...)

On August 30, 2022, the Centers for Medicare & Medicaid Services (CMS) released the financial and quality performance results for the Medicare Shared Savings Program (MSSP) Performance Year (PY) 2021. The results revealed net savings of $1.66 billion for Medicare, marking the fifth consecutive year of savings. In total, 58% of MSSP accountable care organizations (ACOs) achieved savings as a result of their performance. This Health Capital Topics article will discuss the 2021 performance results, which are being released on the eve of seismic changes to the MSSP. (Read more...)

On September 5, 2022, CVS Health announced that it reached an agreement to acquire Signify Health for a total of $8 billion. Under the terms of the deal, CVS will pay Signify $30.50 per share, a valuation of 40x earnings before interest, taxes, depreciation, and amortization (EBITDA). One industry commentator noted that this valuation is “expensive relative to where other healthcare services are trading…but may reflect that they’re EBITDA positive…[and] may be an attempt to get to parity with [competitors] Humana and UnitedHealth Group. Both have far more developed in-home capabilities.” (Read more...) 

Healthcare organizations and providers are increasingly seeking partnerships (often with healthcare tech companies that have developed a compatible medical device) to facilitate their provision of remote therapeutic monitoring (RTM) services to eligible patients. Because only a licensed healthcare provider can bill for RTM services, these arrangements often involve the provider compensating the device manufacturer for the devices used to perform the RTM. Such arrangements typically fall under the purview of federal fraud and abuse laws such as the Anti-Kickback Statute (AKS) and the Stark Law. This third installment of the five-part series on the valuation of RTM will discuss these regulatory hurdles. (Read more...) 
"Physician Compensation Surveys - Is the New Normal Here?" authored by HCC President, Todd A. Zigrang, MBA, MHA, FACHE, CVA, ASA, and, HCC Senior Vice President and General Counsel, Jessica Bailey-Wheaton, Esq., was published by the National Association of Certified Valuators and Analysts (NACVA) in The Value Examiner.

For more recently published material written by HCC, please visit www.healthcapital.com

On June 8, 2022, HCC's Todd A. Zigrang, MBA, MHA, FACHE, CVA, ASA, and Jessica L. Bailey-Wheaton, Esq., presented during the NSCHBC 2022 Annual Conference. The presentation covered "Healthcare Regulatory Updates: Mid-Year Review and Implications for 2022 and Beyond". Be sure to download the entire slide deck of the presentation below.

For more information on the valuation of urgent care centers, including HCC's experience and services related to these enterprises, please email us at solutions@healthcapital.com or call us at (800) FYI-VALU